)
Visual
earnings real time
Supernus Pharmaceuticals (SUPN) investor relations material
Supernus Pharmaceuticals BofA Securities CNS Therapeutics Virtual Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.BofA Securities CNS Therapeutics Virtual Conference 2025 summary8 Dec, 2025
Business development and integration
Integration of the Sage acquisition is progressing ahead of expectations, with significant SG&A cost reductions and a target of $200 million in annualized synergies by the first full year post-acquisition.
R&D programs from Sage are being holistically evaluated alongside internal discovery efforts to prioritize long-term investments.
Early-stage assets from Sage are under review, with optimism about integration and synergy realization.
Product performance and market dynamics
ZURZUVAE has shown sequential quarterly growth of 19%-20%, driven by demand and recent sales force expansion.
The product targets postpartum depression, with 500,000 women affected annually, but diagnosis and treatment rates remain below potential, highlighting ongoing education needs.
About 80% of ZURZUVAE prescriptions are from OB-GYNs, with the rest from psychiatrists; market building and awareness are key growth drivers.
Qelbree growth and market trends
Qelbree continues robust growth in both pediatric and adult ADHD segments, with 19% growth in pediatric and 32% in adult prescriptions during the back-to-school season.
The product is annualizing at over 1 million prescriptions, with significant market penetration opportunity remaining.
About 30%-35% of Qelbree patients are treatment-naive, and the product is gaining share from both non-stimulant and stimulant users.
Qelbree differentiates itself by providing rapid efficacy as early as week one, appealing to both pediatric and adult patients seeking alternatives to stimulants.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Supernus Pharmaceuticals earnings date
Q4 202525 Feb, 2026
Next Supernus Pharmaceuticals earnings date
Q4 202525 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Supernus Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for central nervous system (CNS) disorders. The company specializes in therapies for neurological and psychiatric conditions, including epilepsy, attention deficit hyperactivity disorder (ADHD), and depression. Supernus Pharmaceuticals Inc. is headquartered in Rockville, Maryland, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage